Cognitive
13
0
1
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 8 completed trials
Clinical Trials (13)
Intraoperative Ketamine Versus Lidocaine Infusion on Postoperative Cognitive Dysfunction in Patients Undergoing Hip Surgery
Efficacy and Safety of Individualized Sequential Accelerated Theta Burst Stimulation in Improving Cognitive Function in Schizophrenia
Cognitive Outcomes in BAD-related Stroke
Multisensory Environment-Based Occupational Therapy for Alzheimer's Patients
The Acute Effects of Onnit Alpha Brain on Cognition and Mood States
Validation and Reliability of the Turkish Version of the Montreal Cognitive Assessment-Basic (MoCA-B) in Individuals With Low Educational Level
Nurse-Led Elderly Sleep Intervention
Cognitive Health Awareness Program in Surgical Patients
Non-Invasive Detection and Preservation of Neurocognitive Signals in the Peri-Death Period Using Brain-Computer Interface and Artificial Intelligence
To Evaluate the Efficacy of Lutemax 2020 on Vision and Cognitive Performance in Health Children.
Multimodal Brain Function in Migraine Patients With Patent Foramen Ovale
A Predictive Model for Postoperative Delirium in Kidney Transplant Patients
Acute Nerve Stimulation For Enhancing Human and Cognitive Performance